blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4159224

EP4159224 - SYNBIOTIC COMPOSITION FOR PREVENTING CHRONIC INFLAMMATION [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  03.03.2023
Database last updated on 14.09.2024
Most recent event   Tooltip25.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
N.V. Nutricia
Eerste Stationsstraat 186
2712 HM Zoetermeer / NL
[2023/14]
Inventor(s)01 / Engels, Eefje
3584 CT Utrecht / NL
02 / van Limpt, Cornelus Johannes Petrus
3584 CT Utrecht / NL
03 / Oosting, Annemarie
3584 CT Utrecht / NL
04 / Oozeer, Akhtar Raish
3584 CT Utrecht / NL
05 / Knol, Jan
3584 CT Utrecht / NL
06 / Mischke, Mona
3584 CT Utrecht / NL
 [2023/14]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2023/14]
Application number, filing date22195122.129.06.2018
[2023/14]
Priority number, dateEP2017017907030.06.2017         Original published format: EP 17179070
[2023/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4159224
Date:05.04.2023
Language:EN
[2023/14]
Search report(s)(Supplementary) European search report - dispatched on:EP22.12.2022
ClassificationIPC:A61K35/745, A61K9/00, A61K31/715, A23L33/00, A23L33/135, A23L33/21, A61P3/10, A61P29/00
[2023/14]
CPC:
A61K35/745 (EP,US); A23L3/00 (EP); A23L33/135 (EP,US);
A23L33/21 (EP,US); A23L33/40 (EP,US); A61K31/202 (US);
A61K31/702 (EP,US); A61K31/715 (EP,US); A61K9/0095 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/14]
TitleGerman:SYNBIOTISCHE ZUSAMMENSETZUNG ZUR VORBEUGUNG VON CHRONISCHER ENTZÜNDUNG[2023/14]
English:SYNBIOTIC COMPOSITION FOR PREVENTING CHRONIC INFLAMMATION[2023/14]
French:COMPOSITION SYMBIOTIQUE DE PRÉVENTION DE L'INFLAMMATION CHRONIQUE[2023/14]
Examination procedure12.09.2022Examination requested  [2023/14]
05.10.2023Amendment by applicant (claims and/or description)
05.10.2023Date on which the examining division has become responsible
Parent application(s)   TooltipEP18733319.0  / EP3645023
Fees paidRenewal fee
12.09.2022Renewal fee patent year 03
12.09.2022Renewal fee patent year 04
12.09.2022Renewal fee patent year 05
28.06.2023Renewal fee patent year 06
25.06.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XD]WO2006091103  (NUTRICIA NV [NL], et al) [XD] 1-3,5-10 * page 14; claims 1,13,16 *;
 [Y]WO2008116700  (NESTEC SA [CH], et al) [Y] 1-10 * claims 1-11 *;
 [XI]WO2008153377  (NUTRICIA NV [NL], et al) [X] 1-3,5-10 * page 19; example 2 * [I] 4;
 [XI]WO2009144137  (NESTEC SA [CH], et al) [X] 1-3,5-10 * claims 1-3,8-16 * [I] 4;
 [Y]EP2143341  (NESTEC SA [CH]) [Y] 1-10 * paragraph [0024]; claims 1,15,17 *;
 [Y]WO2011012655  (NESTEC SA [CH], et al) [Y] 1-10 * page 8; claims 1,5,6,8,17 *;
 [Y]EP2359838  (ARAGAN [FR]) [Y] 1-10* paragraphs [0050] , [0072]; claim 14 *;
 [XI]WO2011149335  (NUTRICIA NV [NL], et al) [X] 1-3,5-10 * example 1; table 1 * [I] 4;
 [Y]EP2452571  (NESTEC SA [CH]) [Y] 1-10 * paragraph [0037]; claims 4,7,17-19 *;
 [Y]WO2013054002  (GUT GUIDE OY [FI]) [Y] 1-10 * paragraph [0018]; example 3; claims 1-3 *;
 [Y]WO2015172191  (MEDLAB IP PTY LTD [AU]) [Y] 1-10 * paragraphs [0127] , [0129] , [0136]; claims 3-6 *;
 [Y]WO2016020495  (NESTEC SA [CH]) [Y] 1-10 * page 18, paragraph 1 * * claims 1,8,10 *;
 [Y]WO2016026684  (NESTEC SA [CH]) [Y] 1-10 * claims 1-11 *;
 [X]WO2017043962  (NUTRICIA NV [NL]) [X] 1-10 * example 1; claims 1,3,9 *;
 [Y]WO2017043963  (NUTRICIA NV [NL]) [Y] 1-10 * example 1; claim 1 *;
 [YP]WO2017129649  (NESTEC SA [CH]) [YP] 1-10 * claims 10,18 *;
 [X]  - KUITUNEN M ET AL, "Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 123, no. 2, doi:10.1016/J.JACI.2008.11.019, ISSN 0091-6749, (20090201), pages 335 - 341, (20090108), XP025907147 [X] 1-5,8 * page 335 *

DOI:   http://dx.doi.org/10.1016/j.jaci.2008.11.019
by applicantWO2004093899
 WO2006091103
 WO2007073194
 US7410653
 WO2011096808
 US9480670
    - STACKEBRANDTGOEBEL, Int. J. Syst. Bacteriol., (19940000), vol. 44, pages 846 - 849
    - L. PROSKY et al., J. Assoc. Off. Anal. Chem., (19880000), vol. 71, pages 1017 - 1023
    - SWINBURN et al., Prev Med, (19990000), vol. 29, pages 563 - 570
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.